The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction - Barton, P; Jobanputra, P; Wilson, J; Bryan, S; Burls, A (HEALTH TECHNOLOGY ASSESSMENT, 2004)